FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Stock Short Interest Rises 812.8%

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) was the target of a significant growth in short interest during the month of September. As of September 15th, there was short interest totaling 31,190 shares, a growth of 812.8% from the August 31st total of 3,417 shares. Based on an average trading volume of 5,406 shares, the days-to-cover ratio is presently 5.8 days. Currently, 0.4% of the company’s stock are sold short.

FT Vest U.S. Equity Deep Buffer ETF – October Stock Performance

Shares of FT Vest U.S. Equity Deep Buffer ETF – October stock traded up $0.01 during trading on Thursday, hitting $48.00. 2,365 shares of the stock traded hands, compared to its average volume of 10,965. The stock has a market cap of $395.04 million, a P/E ratio of 24.90 and a beta of 0.37. FT Vest U.S. Equity Deep Buffer ETF – October has a twelve month low of $42.76 and a twelve month high of $48.42. The company has a fifty day moving average price of $47.45 and a two-hundred day moving average price of $46.19.

Institutional Investors Weigh In On FT Vest U.S. Equity Deep Buffer ETF – October

An institutional investor recently raised its position in FT Vest U.S. Equity Deep Buffer ETF – October stock. Winnow Wealth LLC raised its stake in FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) by 4,725.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 121,993 shares of the company’s stock after purchasing an additional 119,465 shares during the period. FT Vest U.S. Equity Deep Buffer ETF – October makes up approximately 4.1% of Winnow Wealth LLC’s holdings, making the stock its 5th biggest position. Winnow Wealth LLC owned 1.48% of FT Vest U.S. Equity Deep Buffer ETF – October worth $5,490,000 as of its most recent SEC filing.

FT Vest U.S. Equity Deep Buffer ETF – October Company Profile

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.